Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer - WP3: Radiobiologie, instrumentation et modèles pour une thérapie innovante Access content directly
Journal Articles Radiotherapy & Oncology Year : 2019

Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer

Abstract

Highlights •MRT is a form of synchrotron generated X-ray radiosurgery dedicated to brain tumours. •Normal tissue tolerates high X-ray dose thanks through lattice of microbeams. •MRT operates at very high dose rate (kGy·s−1) and triggers FLASH effect in vivo.AbstractThis paper reviews the current state of the art of an emerging form of radiosurgery dedicated to brain tumour treatment and which operates at very high dose rate (kGy·s−1). Microbeam Radiation Therapy uses synchrotron-generated X-rays which triggered normal tissue sparing partially mediated by FLASH effect.
Fichier principal
Vignette du fichier
S0167814019329706.pdf (560.81 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02510707 , version 1 (20-07-2022)

Licence

Attribution - NonCommercial

Identifiers

Cite

Laura Eling, Audrey Bouchet, Christian Nemoz, Valentin Djonov, Jacques Balosso, et al.. Ultra high dose rate Synchrotron Microbeam Radiation Therapy. Preclinical evidence in view of a clinical transfer. Radiotherapy & Oncology, 2019, 139, pp.56-61. ⟨10.1016/j.radonc.2019.06.030⟩. ⟨hal-02510707⟩
47 View
119 Download

Altmetric

Share

Gmail Facebook X LinkedIn More